Barclays
ZEPP

Barclays’s Zepp Health ZEPP Stock Holding History

Barclays’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,291
Closed -$87.1K – 5682
2026
Q1 		$87.1K Sell
7,291
-2,475
-25% -$50.7K ﹤0.01% 4085
2025
Q4 		$263K Sell
9,766
-4,281
-30% -$153K ﹤0.01% 4180
2025
Q3 		$643K Buy
+14,047
New +$426K ﹤0.01% 3640
2020
Q4 		– Sell
-6,675
Closed -$343K – 5187
2020
Q3 		$343K Hold
6,675
– – ﹤0.01% 3495
2020
Q2 		$330K Buy
+6,675
New +$308K ﹤0.01% 3663
2019
Q3 		– Sell
-632
Closed -$25K – 7188
2019
Q2 		$25K Buy
+632
New +$26.4K ﹤0.01% 6365

Other funds holding ZEPP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays's ZEPP Position: Q2 2026 in Review

Barclays sold out of Zepp Health (ZEPP) in Q2 2026, closing a stake of 7,291 shares — an estimated $87.1K sold.

Barclays first reported a position in ZEPP in Q2 2019 and held it in 6 quarters. The position peaked at $643K in Q3 2025. 28 funds tracked by Wall St. Rank hold ZEPP as of Q2 2026.

  • Barclays reported no remaining Zepp Health position as of Q2 2026 after selling out during the quarter.
  • Barclays sold 7,291 Zepp Health shares in Q2 2026, an estimated $87.1K.
  • Barclays first reported a position in Zepp Health in Q2 2019 and held it in 6 quarters.
  • Barclays's Zepp Health position peaked at $643K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Zepp Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.